Detalles de la búsqueda
1.
Nanocarriers in cancer clinical practice: a pharmacokinetic issue.
Nanomedicine;
13(2): 583-599, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27520727
2.
Cross-validation of a mass spectrometric-based method for the therapeutic drug monitoring of irinotecan: implementation of matrix-assisted laser desorption/ionization mass spectrometry in pharmacokinetic measurements.
Anal Bioanal Chem;
408(19): 5369-77, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-27235158
3.
Clinical validity of a DPYD-based pharmacogenetic test to predict severe toxicity to fluoropyrimidines.
Int J Cancer;
137(12): 2971-80, 2015 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26099996
4.
Development and validation of a HPLC-UV method for the quantification of antiepileptic drugs in dried plasma spots.
Clin Chem Lab Med;
53(3): 435-44, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25153419
5.
A new high-performance liquid chromatography-tandem mass spectrometry method for the determination of sunitinib and N-desethyl sunitinib in human plasma: Light-induced isomerism overtaking towards therapeutic drug monitoring in clinical routine.
J Pharm Biomed Anal;
179: 112949, 2020 Feb 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31784210
6.
Analytical aspects of sunitinib and its geometric isomerism towards therapeutic drug monitoring in clinical routine.
J Pharm Biomed Anal;
160: 360-367, 2018 Oct 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-30119000
7.
Peptide biosensors for anticancer drugs: Design in silico to work in denaturizing environment.
Biosens Bioelectron;
100: 298-303, 2018 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28942212
8.
A new high-performance liquid chromatography-tandem mass spectrometry method for the determination of paclitaxel and 6α-hydroxy-paclitaxel in human plasma: Development, validation and application in a clinical pharmacokinetic study.
PLoS One;
13(2): e0193500, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29474420
9.
Candidate germline polymorphisms of genes belonging to the pathways of four drugs used in osteosarcoma standard chemotherapy associated with risk, survival and toxicity in non-metastatic high-grade osteosarcoma.
Oncotarget;
7(38): 61970-61987, 2016 Sep 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-27566557
Resultados
1 -
9
de 9
1
Próxima >
>>